HSBC Holdings
GBT

HSBC Holdings’s Global Blood Therapeutics, Inc. GBT Stock Holding History

HSBC Holdings’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-200
Closed -$9K – 3253
2020
Q4 		$9K Buy
+200
New +$9.86K ﹤0.01% 3016

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HSBC Holdings's GBT Position: Q4 2022 in Review

HSBC Holdings sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 189,723 shares — an estimated $12.9M sold.

HSBC Holdings first reported a position in GBT in Q3 2019 and held it in 12 quarters. The position peaked at $12.9M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • HSBC Holdings reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • HSBC Holdings sold 189,723 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $12.9M.
  • HSBC Holdings first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 12 quarters.
  • HSBC Holdings's Global Blood Therapeutics, Inc. position peaked at $12.9M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on HSBC Holdings's 13F filing for Q4 2022, filed 14 Feb 2023.